12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks showed significant movement. Societal CDMO, Apollomics, Elicio Therapeutics, Scinai Immunotherapeutics, Renalytix, and PepGen were among the gainers, with increases ranging from 10.1% to 23.4%. Conversely, CytoMed Therapeutics, NanoString Technologies, Kazia Therapeutics, Exicure, GRI Bio, and Oragenics experienced declines between 7.76% and 16.9%. These movements reflect notable volatility in the healthcare sector, impacting the market value of these companies.
February 07, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollomics shares increased by 19.86%, reflecting positive market momentum.
The notable rise in APLM's stock price could be attributed to investor optimism about the company's prospects or developments within the healthcare sector.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Societal CDMO shares surged 23.4% in pre-market, indicating strong investor interest.
The significant pre-market increase in SCTL's stock price suggests positive investor sentiment, potentially due to favorable company news or broader sector movements.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
CytoMed Therapeutics shares fell by 16.9%, indicating potential concerns among investors.
The decline in GDTC's stock price suggests negative sentiment, possibly due to unfavorable news or broader market trends affecting the healthcare sector.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
NanoString Technologies shares decreased by 14.95%, reflecting negative market reaction.
NSTG's stock price decline could be a result of investor pessimism, potentially due to company-specific issues or negative trends within the sector.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90